Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial - Concepedia

Concepedia

Publication | Closed Access

Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial

47

Citations

28

References

2013

Year

Javier Arpa, Irene Sanz‐Gallego, Francisco Javier Rodríguez de Rivera Garrido, Francisco J. Domínguez-Melcón, Daniel Prefasi, Javier Oliva-Navarro, Mar Moreno-Yangüela

Acta Neurologica Scandinavica

Abstract

Our results seem to indicate some uncertain benefit on the neurological and heart functions of this triple therapy in FRDA.

References

	Year	Citations
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology Roberto M. Lang, Michelle Bierig, Richard B. Devereux, Journal of the American Society of Echocardiography Standards CommitteeCardiovascular DiseasePatient SafetyCardiac PathologyOutcomes Research	2005	11.3K
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion Victoria Campuzano, Laura Montermini, María Dolores Moltó, Science	1996	2.7K
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia Alexandra Dürr, Mireille Cossée, Yves Agid, New England Journal of Medicine	1996	1.1K
FRIEDREICH'S ATAXIA: A CLINICAL AND GENETIC STUDY OF 90 FAMILIES WITH AN ANALYSIS OF EARLY DIAGNOSTIC CRITERIA AND INTRAFAMILIAL CLUSTERING OF CLINICAL FEATURES A E Harding Brain	1981	913
Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin Hana Koutníková, Victoria Campuzano, Françoise Foury, Nature Genetics BiologyMitophagyMitochondrial FunctionOrganelle DynamicNatural Sciences	1997	470
Selective iron chelation in Friedreich ataxia: biologic and clinical implications Nathalie Boddaert, Kim‐Hanh Le Quan Sang, Agnès Rötig, Blood	2007	405
The natural history of degenerative ataxia: a retrospective study in 466 patients Thomas Klockgether Brain Disease ProgressionNeurological DisorderCorticobasal DegenerationGeneticsGenetic Epidemiology	1998	384
Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotes Mireille Coss�e, Alexandra D�rr, Mich�le Schmitt, Annals of Neurology	1999	382
Mortality in Friedreich Ataxia Amy Y. Tsou, Erin K. Paulsen, Sarah J. Lagedrost, Journal of the Neurological Sciences Disease ProgressionEpidemiological OutcomeDegenerative DiseaseNeurologyMedicine	2011	298
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial Nicholas A. Di Prospero, Angela Baker, Neal Jeffries, The Lancet Neurology Neurodegenerative DiseasesAlzheimer's DiseaseNeurological DisorderHigh-dose IdebenoneNeuropharmacology	2007	297

Page 1